{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T15:41:14Z","timestamp":1688917274352},"reference-count":35,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1210\/jcem.85.9.6823","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:07Z","timestamp":1389200767000},"page":"3383-3390","source":"Crossref","is-referenced-by-count":2,"title":["High-Dose Growth Hormone Does Not Affect Proinflammatory Cytokine (Tumor Necrosis Factor-\u03b1, Interleukin-6, and Interferon-\u03b3) Release from Activated Peripheral Blood Mononuclear Cells or after Minimal to Moderate Surgical Stress*"],"prefix":"10.1210","volume":"85","author":[{"given":"S. H.","family":"Zarkesh-Esfahani","sequence":"first","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kolstad","sequence":"additional","affiliation":[{"name":"Tromso University (O.K., A.R.), Tromso, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Metcalfe","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F.","family":"Watson","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Von Laue","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Walters","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Revhaug","sequence":"additional","affiliation":[{"name":"Tromso University (O.K., A.R.), Tromso, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Weetman","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J. M.","family":"Ross","sequence":"additional","affiliation":[{"name":"Division of Clinical Sciences and SCHARR (S.W.), Sheffield University, Sheffield, United Kingdom S5 7AU"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114165397300_R1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJM199109053251005","article-title":"Catabolic illness. Strategies for enhancing recovery.","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114165397300_R2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","volume":"341","author":"Takala","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114165397300_R3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2362.1996.140268.x","article-title":"Growth hormone potentiates the in vivo biological activities of endotoxin in the rat.","volume":"26","author":"Liao","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t2019041114165397300_R4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000008562","article-title":"Treatment with growth hormone and insulin-like growth factor-1 in septicemia: effects on carbohydrate metabolism.","volume":"30","author":"Balteskard","year":"1998","journal-title":"Eur Surg Res"},{"key":"key\n\t\t\t\t2019041114165397300_R5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/edrv.18.2.0296","article-title":"The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function.","volume":"18","year":"1997","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114165397300_R6","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1210\/endo.140.7.6854","article-title":"Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: relation with age and GH-binding protein.","volume":"140","author":"Bresson","year":"1999","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114165397300_R7","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1096\/fasebj.2.12.3044906","article-title":"Production of immunoreactive growth hormone by mononuclear leukocytes.","volume":"2","author":"Weigent","year":"1988","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019041114165397300_R8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/edrv-15-5-627","article-title":"Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines.","volume":"15","author":"Horseman","year":"1994","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114165397300_R9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1530\/eje.0.1380640","article-title":"Modulating effect of human growth hormone on tumour necrosis factor-\u03b1 and interleukin-1\u03b2.","volume":"138","author":"Bozzola","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114165397300_R10","first-page":"58","article-title":"Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.","volume":"84","author":"Serri","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114165397300_R11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00002030-199808000-00012","article-title":"Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients.","volume":"12","author":"Nguyen","year":"1998","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041114165397300_R12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s001340050533","article-title":"Effects of human recombinant growth hormone (rhGH) on inflammatory responses in patients undergoing abdominal aortic aneurysm repair.","volume":"24","author":"Mealy","year":"1998","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019041114165397300_R13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/s-2007-1001771","article-title":"In vitro effects of human growth hormone on the proliferative responses and cytokine production of blood mononuclear cells.","volume":"26","author":"Kappel","year":"1994","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041114165397300_R14","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1074\/jbc.274.21.14791","article-title":"Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling.","volume":"274","author":"Maamra","year":"1999","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041114165397300_R15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/mend.11.3.9901","article-title":"A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.","volume":"11","author":"Ross","year":"1997","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041114165397300_R16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.256.5064.1677","article-title":"Rational design of potent antagonists to the human growth hormone receptor.","volume":"256","author":"Fuh","year":"1992","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041114165397300_R17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/qjmed\/89.11.813","article-title":"Growth hormone therapy for protein catabolism.","volume":"89","author":"Jenkins","year":"1996","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t2019041114165397300_R18","article-title":"Cytokines and cytokine receptors, 2nd Ed","author":"Male","year":"1993"},{"key":"key\n\t\t\t\t2019041114165397300_R19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000018600","article-title":"Cytokines in surgical trauma: cholecystectomy as an example.","volume":"15","author":"Reber","year":"1998","journal-title":"Digest Surg"},{"key":"key\n\t\t\t\t2019041114165397300_R20","first-page":"24","article-title":"Endocrine and immune response to injury after open and laparoscopic cholecystectomy.","volume":"83","author":"Bellon","year":"1998","journal-title":"Int Surg"},{"key":"key\n\t\t\t\t2019041114165397300_R21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000129504","article-title":"Cytokine levels after open and laparoscopic cholecystectomy.","volume":"29","author":"Bellon","year":"1997","journal-title":"Eur Surg Res"},{"key":"key\n\t\t\t\t2019041114165397300_R22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF01655116","article-title":"Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function.","volume":"17","author":"Vara-Thorbeck","year":"1993","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041114165397300_R23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00000658-199010000-00005","article-title":"Effects of recombinant human growth hormone on donor-site healing in severely burned children.","volume":"212","author":"Herndon","year":"1990","journal-title":"Ann Surgery"},{"key":"key\n\t\t\t\t2019041114165397300_R24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00005373-199101000-00015","article-title":"Improvement of septic syndrome after administration of recombinant human growth hormone (rhGH)?","volume":"31","author":"Gottardis","year":"1991","journal-title":"J Trauma-Injury Infect Crit Care"},{"key":"key\n\t\t\t\t2019041114165397300_R25","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.154.4.1909","article-title":"Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2.","volume":"154","author":"Warwick-Davies","year":"1995","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019041114165397300_R26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1210\/endo-128-2-989","article-title":"Hypophysectomy inhibits the synthesis of tumor necrosis factor alpha by rat macrophages: partial restoration by exogenous growth hormone or interferon gamma.","volume":"128","author":"Edwards","year":"1991","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114165397300_R27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/endo.134.3.8119146","article-title":"Recombinant bovine somatotropin blunts plasma tumor necrosis factor-\u03b1, cortisol, and thromboxane-B2 responses to endotoxin in vivo.","volume":"134","author":"Elsasser","year":"1994","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114165397300_R28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archsurg.1995.01430100093018","article-title":"Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model.","volume":"130","author":"Inoue","year":"1995","journal-title":"Arch Surg"},{"key":"key\n\t\t\t\t2019041114165397300_R29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00000658-199807000-00016","article-title":"Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice.","volume":"228","author":"Takagi","year":"1998","journal-title":"Ann Surg"},{"key":"key\n\t\t\t\t2019041114165397300_R30","first-page":"83","article-title":"Growth hormone release of interleukin-1 alpha, interferon-gamma and interleukin-4 from murine splenocytes stimulated with staphylococcal protein A, toxic shock syndrome toxin-1 and streptococcal lysin S.","volume":"8","author":"Galdiero","year":"1997","journal-title":"Eur Cytokine Network"},{"key":"key\n\t\t\t\t2019041114165397300_R31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1099\/00222615-45-1-40","article-title":"Growth hormone modulates IL-\u03b1 and IFN-\u03b3 release by murine splenocytes activated by LPS or porins of Salmonella typhimurium.","volume":"45","author":"Sommese","year":"1996","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t2019041114165397300_R32","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1073\/pnas.87.13.5061","article-title":"Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice.","volume":"87","author":"Chen","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114165397300_R33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/mend-5-12-1845","article-title":"Glycine 119 of bovine growth hormone is critical for growth-promoting activity.","volume":"5","author":"Chen","year":"1991","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t2019041114165397300_R34","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/endo-129-3-1402","article-title":"Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.","volume":"129","author":"Chen","year":"1991","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114165397300_R35","doi-asserted-by":"crossref","first-page":"15892","DOI":"10.1016\/S0021-9258(17)40764-2","article-title":"In vitro and in vivo studies of antagonistic effects of human growth hormone analogs [published erratum appears in J Biol Chem 1994 Aug 12;269(32):20806].","volume":"269","author":"Chen","year":"1994","journal-title":"J Biol Chem"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/9\/3383\/9062870\/jcem3383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:58:37Z","timestamp":1688914717000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/9\/3383\/2660676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.9.6823","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,1]]}}}